New pain block study aims to improve shoulder surgery recovery
NCT ID NCT06826846
First seen Jun 26, 2026 · Last updated Sep 02, 2026 · Updated 5 times
Summary
This study tested two methods of a nerve block for pain after arthroscopic shoulder surgery. One group received a single injection of numbing medicine before surgery, while the other group also had a small tube placed to deliver additional medicine every 8 hours after surgery. The goal was to see if the continuous method provides better pain relief, less opioid use, and higher patient satisfaction. The study involved 90 adults aged 18-80.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- bupivacaine
- What this could lead to
- If the catheter method works better, it could offer longer-lasting pain relief after shoulder surgery, reducing the need for strong painkillers.
- What could go wrong
- This is a small, completed study. The catheter method may not provide significantly better pain control and could carry a higher risk of infection or complications from the catheter.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
90 people
The number who actually took part.
- Started
-
Mar 2025
- Finished
-
Oct 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 80 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Aged between 18-80 years * No bleeding diathesis * Classified as ASA I-II-III Exclusion Criteria: * Patients who do not provide consent * Patients with coagulopathy * History of allergy or intoxication to local anesthetic agents * Patients with advanced organ failure * History of neuropathic disease * Patients with mental retardation * Presence of infection at the injection site * Conditions in which regional anesthesia is contraindicated * Pediatric patients and those over 80 years of age * Pregnant patients
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Arthroscopic shoulder surgery are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Goztepe Suleyman Yalcin City Hospital
Istanbul, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a steroid extend pain relief after shoulder surgery?
- Can a new nerve block beat standard pain relief for shoulder surgery?
- Shoulder block study checks for breathing side effects
- Shoulder surgery nerve block showdown: which one spares your diaphragm?
- New nerve block may ease shoulder pain without harming breathing
- New painkiller could cut opioid use after shoulder surgery